Your browser doesn't support javascript.
loading
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
Zhang, Leo; Nomie, Krystle; Zhang, Hui; Bell, Taylor; Pham, Lan; Kadri, Sabah; Segal, Jeremy; Li, Shaoying; Zhou, Shouhao; Santos, David; Richard, Shawana; Sharma, Shruti; Chen, Wendy; Oriabure, Onyekachukwu; Liu, Yang; Huang, Shengjian; Guo, Hui; Chen, Zhihong; Tao, Wenjing; Li, Carrie; Wang, Jack; Fang, Bingliang; Wang, Jacqueline; Li, Lei; Badillo, Maria; Ahmed, Makhdum; Thirumurthi, Selvi; Huang, Steven Y; Shao, Yiping; Lam, Laura; Yi, Qing; Wang, Y Lynn; Wang, Michael.
Affiliation
  • Zhang L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nomie K; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bell T; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pham L; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadri S; Divison of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
  • Segal J; Divison of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
  • Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhou S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Santos D; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Richard S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sharma S; Divison of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
  • Chen W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Oriabure O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu Y; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Guo H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tao W; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fang B; Department of Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang J; Department of Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Li L; Department of Experimental Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Badillo M; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ahmed M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thirumurthi S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang SY; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shao Y; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lam L; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yi Q; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang YL; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
  • Wang M; Divison of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois.
Clin Cancer Res ; 23(15): 4212-4223, 2017 Aug 01.
Article in En | MEDLINE | ID: mdl-28348046
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Protein-Tyrosine Kinases / Lymphoma, Large B-Cell, Diffuse / Protein Kinase Inhibitors Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyrimidines / Protein-Tyrosine Kinases / Lymphoma, Large B-Cell, Diffuse / Protein Kinase Inhibitors Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United States